EML section
Any
1. Anaesthetics, preoperative medicines and medical gases (17)
1.1. General anaesthetics and oxygen (9)
1.1.1. General anaesthetics and oxygen > Inhalational medicines (6)
1.1.2. General anaesthetics and oxygen > Injectable medicines (3)
1.2. Local anaesthetics (4)
1.3. Preoperative medication and sedation for short-term procedures (3)
1.4. Medical gases (1)
2. Medicines for pain and palliative care (31)
2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) (4)
2.2. Opioid analgesics (8)
2.3. Medicines for other common symptoms in palliative care (19)
3. Antiallergics and medicines used in anaphylaxis (8)
4. Antidotes and other substances used in poisonings (19)
4.1. Antidotes and other substances used in poisonings > Non-specific (2)
4.2. Antidotes and other substances used in poisonings > Specific (17)
5. Medicines for diseases of the nervous system (8)
5. Medicines for neurological disorders (65)
6. Anti-infective medicines (482)
6.1. Anthelminthics (47)
6.1.1. Intestinal anthelminthics (28)
6.1.2. Antifilarials (7)
6.1.3. Antischistosomals and other antitrematode medicines (8)
6.2. Antibacterials (263)
6.2.1. Access group antibiotics (100)
6.2.2. Watch group antibiotics (79)
6.2.4. Antileprosy medicines (3)
6.2.5. Antituberculosis medicines (40)
6.3. Antifungal medicines (25)
6.4. Antiviral medicines (65)
6.4.1. Antiherpes medicines (6)
6.4.2. Antiretrovirals (39)
6.4.2.1. Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors (8)
6.4.2.2. Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors (2)
6.4.2.3. Antiretrovirals > Protease inhibitors (8)
6.4.2.4. Antiretrovirals > Integrase inhibitors (2)
6.4.2.6. Medicines for prevention of HIV-related opportunistic infections (1)
6.4.3. Other antivirals (3)
6.4.4. Antihepatitis medicines (17)
6.4.4.1. Medicines for hepatitis B (3)
6.4.4.1.1. Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors (3)
6.4.4.2. Medicines for hepatitis C (14)
6.4.4.2.1. Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations (6)
6.4.4.2.2. Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations (5)
6.4.4.2.3. Medicines for hepatitis C > Other antivirals for hepatitis C (3)
6.5. Antiprotozoal medicines (75)
6.5.1. Antiamoebic and antigiardiasis medicines (4)
6.5.2. Antileishmaniasis medicines (12)
6.5.4. Antipneumocystosis and antitoxoplasmosis medicines (4)
6.5.3. Antimalarial medicines (43)
6.5.3.1. Antimalarial medicines > For curative treatment (1)
6.5.3.1. Antimalarial medicines > Medicines for curative treatment (28)
6.5.3.2. Antimalarial medicines > For chemoprevention (3)
6.5.3.2. Antimalarial medicines > Medicines for chemoprevention (8)
6.5.5. Antitrypanosomal medicines (12)
6.5.5.1. African trypanosomiasis (10)
6.5.5.2. American trypanosomiasis (2)
7. Medicines for cystic fibrosis (3)
8. Immunomodulators and antineoplastics (386)
8.1. Immunomodulators for non-malignant disease (22)
8.2. Antineoplastics and supportive medicines (364)
9. Therapeutic foods (1)
10. Medicines affecting the blood (58)
10.1. Antianaemia medicines (18)
10.2. Medicines affecting coagulation (32)
10.3. Other medicines for haemoglobinopathies (8)
11. Blood products of human origin and plasma substitutes (9)
11. Blood products, coagulation factors, and plasma substitutes (22)
11.1. Blood and blood components (12)
11.2. Human immunoglobulins (7)
11.2. Plasma-derived medicines (1)
12. Cardiovascular medicines (92)
12.1. Antianginal medicines (9)
12.2. Antiarrhythmic medicines (13)
12.3. Antihypertensive medicines (25)
12.4. Medicines used in heart failure (18)
12.6. Lipid-lowering agents (10)
12.5. Antithrombotic medicines (8)
12.5.1. Anti-platelet medicines (6)
12.5.2. Thrombolytic medicines (2)
13. Dermatological medicines (59)
13.1. Dermatological medicines > Antifungal medicines (7)
13.2. Dermatological medicines > Anti-infective medicines (7)
13.3. Dermatological medicines > Anti-inflammatory and antipruritic medicines (9)
13.4. Dermatological medicines > Medicines affecting skin differentiation and proliferation (20)
13.5. Dermatological medicines > Scabicides and pediculicides (12)
14. Diagnostic agents (8)
14.1. Diagnostic agents > Ophthalmic medicines (4)
14.2. Diagnostic agents > Radiocontrast media (4)
15. Antiseptics and disinfectants (11)
15.1. Antiseptics (6)
15.2. Disinfectants (5)
16. Diuretics (13)
17. Gastrointestinal medicines (32)
17.1. Antiulcer medicines (7)
17.2. Antiemetic medicines (9)
17.3. Anti-inflammatory medicines (9)
17.4. Laxatives (2)
17.5. Medicines used in diarrhoea (4)
17.5.1. Oral rehydration (1)
17.5.2. Medicines for diarrhoea (2)
18. Medicines for endocrine disorders (74)
18.1. Adrenal hormones and synthetic substitutes (4)
18.2. Androgens (1)
18.3. Estrogens (3)
18.5. Medicines for diabetes (42)
18.4. Progestogens (3)
18.7. Thyroid hormones and antithyroid medicines (6)
19. Immunologicals (41)
19.1. Immunologicals > Diagnostic agents (1)
19.2. Immunologicals > Sera, immunoglobulins and monoclonal antibodies (8)
19.3. Immunologicals > Vaccines (32)
20. Muscle relaxants (peripherally-acting) and cholinesterase inhibitors (10)
21. Ophthalmological preparations (61)
21.1. Ophthalmological preparations > Anti-infective agents (33)
21.2. Ophthalmological preparations > Anti-inflammatory agents (4)
21.3. Ophthalmological preparations > Local anaesthetics (1)
21.4. Ophthalmological preparations > Miotics and antiglaucoma medicines (10)
21.5. Ophthalmological preparations > Mydriatics (5)
21.6. Ophthalmological preparations > Anti-vascular endothelial growth factor (VEGF) preparations (5)
22. Medicines for reproductive health and perinatal care (42)
22.3. Uterotonics (6)
22.4. Antioxytocics (tocolytics) (1)
23. Peritoneal dialysis solution (1)
24. Medicines for mental and behavioural disorders (40)
24.1. Medicines for psychotic disorders (16)
24.3. Medicines for anxiety disorders (5)
24.4. Medicines for obsessive compulsive disorders (2)
24.5. Medicines for disorders due to psychoactive substance use (8)
24.2. Medicines for mood disorders (8)
24.2.1. Medicines for depressive disorders (4)
24.2.2. Medicines for bipolar disorders (4)
25. Medicines acting on the respiratory tract (26)
25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease (25)
26. Solutions correcting water, electrolyte and acid–base disturbances (11)
26.1. Solutions correcting water, electrolyte and acid-base disturbances > Oral (2)
26.2. Solutions correcting water, electrolyte and acid-base disturbances > Parenteral (8)
26.3. Solutions correcting water, electrolyte and acid-base disturbances > Miscellaneous (1)
27. Vitamins and minerals (20)
28. Ear, nose and throat medicines [c] (5)
29. Medicines for diseases of joints (23)
6.5.5.1.1. Medicines for the treatment of 1st stage African trypanosomiasis (4)
6.5.5.1.2. Medicines for the treatment of 2nd stage African trypanosomiasis (6)
6.4.2.5. Fixed-dose combinations of antiretrovirals (18)
25.2. Antitussives (1)
6.2.3. Reserve group antibiotics (41)
8.2.1. Cytotoxic medicines (206)
8.2.2. Targeted therapies (37)
8.2.3. Immunomodulators (54)
8.2.4. Hormones and antihormones (49)
8.2.5. Supportive medicines (15)
6.6. Medicines for ectoparasitic infections (1)
18.5.1. Insulins (25)
18.5.2. Hypoglycaemic agents (10)
18.5.2. Oral hypoglycaemic agents (7)
18.6. Medicines for hypoglycaemia (2)
22.1. Contraceptives (18)
22.2. Ovulation inducers (2)
22.5. Other medicines administered to the mother (3)
22.6. Medicines administered to the neonate [c] (4)
22.7. Medicines administered to the neonate [c] (5)
22.1.1. Oral hormonal contraceptives (7)
22.1.2. Injectable hormonal contraceptives (3)
22.1.3. Intrauterine devices (2)
22.1.4. Barrier methods (2)
22.1.5. Implantable contraceptives (2)
22.1.6. Intravaginal contraceptives (2)
29.1. Medicines used to treat gout (3)
29.2. Disease-modifying anti-rheumatic drugs (DMARDs) (8)
29.3. Medicines for juvenile joint diseases (12)
6.1.4. Cysticidal medicines (4)
30. Dental medicines and preparations (5)
6.7. Medicines for Ebola virus disease (2)
5.1. Antiseizure medicines (8)
5.1. Medicines for central nervous system disorders (59)
6.8. Medicines for COVID-19 (1)
24.5.1. Medicines for alcohol use disorders (2)
24.5.2. Medicines for nicotine use disorders (4)
24.5.3. Medicines for opioid use disorders (2)
12.7. Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease (9)
18.8. Medicines for disorders of the pituitary hormone system (3)
5.1.1. Antiseizure medicines (18)
5.1.2. Medicines for multiple sclerosis (6)
5.1.3. Medicines for parkinsonism (5)
5.1.4. Medicines for cerebral palsy (1)
5.1.5. Medicines for headache disorders (16)
5.1.6. Medicines for central nervous system infections (14)
5.1.5.1. Medicines for acute migraine attacks (6)
5.1.5.2. Medicines for migraine prophylaxis (7)
5.1.5.3. Medicines for cluster headache (3)
5.1.6.1. Medicines for bacterial central nervous system infections (8)
5.1.6.2. Medicines for viral central nervous system infections (6)
11.5. Plasma substitutes (4)
11.3. Coagulation factors (7)
13.6. Dermatological medicines > Moisturizers (2)
5.2. Medicines for peripheral nervous system disorders (3)
5.2.1. Medicines for Guillain-Barré syndrome (1)
5.2.2. Medicines for myasthenia gravis (2)
6.5.3.3. Antimalarial medicines > Medicines for chemoprophylaxis in travellers (3)
13.7. Dermatological medicines > Sunscreens (1)
22.4. Medicines for medical abortion (3)
Model List of Essential Medicines